Tyra Biosciences is stepping up its urologic cancer strategy, pursuing new treatments for bladder-related tumors. The focus includes IR-NMIBC and LG-UTUC, along

BWB News TV • 2026-07-22 15:31 UTC • By Billy Odell Tucker-Robinson

Tyra Biosciences is stepping up its urologic cancer strategy, pursuing new treatments for bladder-related tumors. The focus includes IR-NMIBC and LG-UTUC, alongside deeper engagement with clinicians, researchers and patient advocates.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly